PAX6 and type 2 diabetes mellitus: Our recent work (So et al, 2021) has further delineated the mechanism by which PAX6 regulates GSIS in beta cells through modulation of both proximal and distal signaling, while highlighting the pathophysiological role of PAX6 in T2D‐associated beta cell dysfunction.